Alvogen, Inc: Drug Recall
Recall #D-0259-2026 · 12/31/2025
Class II: Risk
Recall Details
- Recall Number
- D-0259-2026
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Alvogen, Inc
- Status
- Ongoing
- Date Initiated
- 12/31/2025
- Location
- Morristown, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
Reason for Recall
Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
Product Description
Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.
Distribution Pattern
US Nationwide.
Other Recalls by Alvogen, Inc
- Class I: Dangerous 01/31/2025
- Class II: Risk 02/06/2023
- Class II: Risk 02/26/2021
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.